首页 > 市场调查报告书 > 医疗设备

心血管设备循环系统

市场调查报告书

商品编码

1671852

心房颤动市场按类型、治疗方法、技术、最终用户和地区划分

Atrial Fibrillation Market, By Type, By Treatment, By Technology, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球心房颤动市场规模估计为 264.3 亿美元，预计到 2032 年将达到 435.7 亿美元，2025 年至 2032 年的复合年增长率为 7.4%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	264.3亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	7.40％	2032 年价值预测	435.7亿美元

数字。 2025 年心房颤动市场占有率（按地区划分）

心房颤动是世界上最常见的心律不整，确诊病例的盛行率正在迅速增加。老年人口的增加、心血管疾病和文明病的盛行率不断上升、侵入性心血管手术的增加以及诊断和治疗设备的技术进步是推动该市场成长的一些主要因素。然而，与心房颤动诊断和治疗相关的血栓性栓塞症风险以及开发中国家对心房颤动缺乏认识预计会阻碍市场的成长。

市场动态：

推动全球心房颤动市场成长的关键因素是易患心房颤动的老年人口的快速增加、肥胖和高血压盛行率的上升、酒精和烟草消费量的增加以及侵入性心血管手术的增加。然而，与心房颤动的诊断和治疗相关的血栓性栓塞症风险高以及新兴国家对心房颤动缺乏认识预计会阻碍市场的成长。新型消融技术的研发以及提供创新解决方案的新兴企业的出现将在未来几年提供重大机会。

本研究的主要特点

本报告对全球心房颤动市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的引人注目的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球心房颤动市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。

这项研究涉及的主要企业包括辉瑞公司、勃林格殷格翰公司、百时美施贵宝公司、强生公司、雅培实验室、波士顿科学公司、美敦力公司、AtriCure 公司、赛诺菲公司、拜耳公司、吉利德科学公司、安进公司和默克公司。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球心房颤动市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过分析全球心房颤动市场所使用的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 26.43 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	US$ 43.57 Bn

Atrial fibrillation is the most common cardiac arrhythmia globally and the prevalence of diagnosed cases is growing rapidly. Rising geriatric population, increasing incidence of cardiovascular & lifestyle diseases, growth in invasive cardiac procedures, and technological advancements in diagnostic and treatment devices are some of the key factors fueling the growth of this market. However, risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are expected to hamper market growth.

Market Dynamics:

The key drivers propelling the growth of global atrial fibrillation market are rapid growth in geriatric population who are more susceptible to atrial fibrillation, rising prevalence of obesity and hypertension, increasing consumption of alcohol and tobacco, and growing number of invasive cardiac surgeries. However, high risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are projected to hinder the market growth. Growing research on development of novel ablation technologies and emergence of start-up companies offering innovative solutions present significant opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, AtriCure, Inc., Sanofi, Bayer AG, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., St. Jude Medical, Inc., and Cardiovascular Systems, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market

Market Segmentation

Type Insights (Revenue, USD Bn, 2020 - 2032)
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Permanent Atrial Fibrillation
Treatment Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmacological Treatments
- Anticoagulants
- Antiarrhythmic Drugs
- Non-Pharmacological Treatments
- Catheter Ablation
- Surgical Procedures
- Implantable Devices
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Radiofrequency
- Laser
- Cryotherapy
- Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Cardiac Centers
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Johnson & Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- AtriCure, Inc.
- Sanofi
- Bayer AG
- Gilead Sciences, Inc.
- Amgen Inc.
- Merck & Co., Inc.
- Jude Medical, Inc.
- Cardiovascular Systems, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Atrial Fibrillation Market, By Type
- Global Atrial Fibrillation Market, By Treatment
- Global Atrial Fibrillation Market, By Technology
- Global Atrial Fibrillation Market, By End User
- Global Atrial Fibrillation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Atrial Fibrillation Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Paroxysmal Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Persistent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Permanent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Atrial Fibrillation Market, By Treatment, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anticoagulants
- Antiarrhythmic Drugs
Non-Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Catheter Ablation
- Surgical Procedures
- Implantable Devices

6. Global Atrial Fibrillation Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Radiofrequency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cryotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Atrial Fibrillation Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Atrial Fibrillation Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AtriCure, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Bayer AG
Gilead Sciences, Inc.
Amgen Inc.
Merck & Co., Inc.
Jude Medical, Inc.
Cardiovascular Systems, Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

心房颤动市场按类型、治疗方法、技术、最终用户和地区划分